Strategic Partners A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OZYMF research report →
About the company
Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev. Historically, its primary focus was on biotechnology; however, it presently conducts no significant business operations.
- CEO
- Jakob Færch Bendtsen
- IPO
- 2019
- Employees
- 1
- HQ
- Copenhagen, DK
Price Chart
- Market Cap
- $3.72M
- P/E
- -28.64
- P/S
- 78.95
- P/B
- 1.34
- EV/EBITDA
- -9.81
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -791.59%
- Net Margin
- -277.99%
- ROE
- -4.71%
- ROIC
- -13.30%
- Revenue
- $309.00K · 0.00%
- Net Income
- $-859,000 · -288155.03%
- EPS
- $-21.00 · -162.50%
- Op Income
- $-2,446,000
- FCF YoY
- 36.59%
- 52W High
- $90.00
- 52W Low
- $0.09
- 50D MA
- $90.00
- 200D MA
- $90.00
- Beta
- 0.27
- Avg Volume
- 2.05K
Get TickerSpark's AI analysis on OZYMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our OZYMF coverage
Recent articles, reports, and earnings notes.
No research on OZYMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OZYMF report →Similar companies
Peers in the same neighborhood.